Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $366.7300 (-1.33%) ($364.5000 - $371.5000) on Mon. Oct. 17, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.81% (three month average) | RSI | 12 | Latest Price | $366.7300(-1.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.4% a day on average for past five trading days. | Weekly Trend | REGN declines -4.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(62%) XLV(50%) XBI(45%) IVW(40%) IWF(40%) | Factors Impacting REGN price | REGN will decline at least -0.905% in a week (0% probabilities). VIXM(-9%) TLT(-8%) UUP(-7%) TIP(-3%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.905% (StdDev 1.81%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
Resistance Level | $395.3 | 5 Day Moving Average | $374.74(-2.14%) | 10 Day Moving Average | $383.01(-4.25%) | 20 Day Moving Average | $395.3(-7.23%) | To recent high | -16.9% | To recent low | 0% | Market Cap | $38.884b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |